The US Food and Drug Administration’s latest regulatory goals update includes October as the target date for publishing final rules on moving more drug ingredients to OTC and on exemptions from investigational new drug clearance for clinical trials to evaluate food, dietary supplements or cosmetics.
The semi-annual regulatory agenda of non-binding target dates published in July also sets a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?